Study of the Survival of Recombinant Human Neuregulin-1β in Chronic Heart Failure (CHF) Patients

NCT01131637 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

331

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor has designed another study to replace the current study

Conditions

Chronic Heart Failure

Interventions

DRUG: rhNRG-1
DRUG: placebo

Sponsor

Zensun Sci. & Tech. Co., Ltd.